[1] 谭玉群,钟水生,王展航,等.抗N-甲基-D-天冬氨酸受体脑炎17例[J].实用医学杂志,2015,31(3):514-515.DOI:10.3969/j.issn.1006-5725.2015.03.060.
[2] Huang Q,Xie Y,Hu Z,et al.Anti-N-methyl-D-aspartate receptor encephalitis: a review of pathogenic mechanisms, treatment, prognosis[J].Brain Res,2020,1727:146549.DOI:10.1016/j.brainres.2019.146549.
[3] Dalmau J,Lancaster E,Martinez-Hernandez E,et al.Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J].Lancet Neurol,2011,10(1):63-74.DOI:10.1016/S1474-4422(10)70253-2.
[4] Florance NR,Davis RL,Lam C,et al.Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents[J].Ann Neurol,2009,66(1):11-18.DOI:10.1002/ana.21756.
[5] 叶晓红,宋成城,傅海群,等.抗N-甲基-D-天冬氨酸受体脑炎的研究进展[J].浙江中西医结合杂志,2019,29(3):251-255.DOI:10.3969/j.issn.1005-4561.2019.03.029.
[6] 冯雪丹,胡永强,冯文良,等. 抗 NMDA 受体脑炎45例特点和临床转归分析[J].脑与神经疾病杂志,2016,24(7):425-429.
[7] Barth A,Nassenstein I,Tröbs RB,et al.N-Methyl-D-Aspartate receptor encephalitis with psychiatric symptoms and an ovarian teratoma detected by MRI in a 17-year-old girl[J].Neuropediatrics,2019,50(4):253-256.DOI:10.1055/s-0039-1692417.
[8] 刘磊,宋兆慧,郭晶,等.国人45例抗N-甲基-D-天冬氨酸受体脑炎病例分析[J].中华神经科杂志,2014,47(7):474-481.
[9] Vignesh P,Singh S.Platelet activation dynamics in kawasaki disease- revisited[J].Indian J Pediatr,2019,86(3):216-217.DOI:10.1007/s12098-019-02890-y.
[10] Matundan HH,Sin J,Rivas MN,et al.Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis[J].JCI Insight,2019,4(3):e126279.DOI:10.1172/jci.insight.126279.
[11] Sugahara-Tobinai A,Inui M,Metoki T,et al.Augmented ILT3/LILRB4 expression of peripheral blood antibody secreting cells in the acute phase of kawasaki disease[J].Pediatr Infect Dis J,2019,38(4):431-438.DOI:10.1097/INF.0000000000002259.
[12] Sato S,Fujita Y,Shigemura T,et al.Juvenile onset autoinflammatory disease due to a novel mutation in TNFAIP3 (A20)[J].Arthritis Res Ther,2018,20(1):274.DOI:10.1186/s13075-018-1766-x.
[13] Dalmau J,Gleichman AJ,Hughes EG,et al.Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies[J].Lancet Neurol,2008,7(12):1091-1098.DOI:10.1016/S1474-4422(08)70224-2.
[14] Titulaer MJ,McCracken L,Gabilondo I,et al.Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J].Lancet Neurol,2013,12(2):157-165.DOI:10.1016/S1474-4422(12)70310-1.
[15] Tanoue T,Morita S,Plichta DR,et al.A defined commensal consortium elicits CD8 T cells and anti-cancer immunity[J].Nature,2019,565(7741):600-605.DOI:10.1038/s41586-019-0878-z.
[16] Okuno Y,Murata T,Sato Y,et al.Defective epstein-barr virus in chronic active infection and haematological malignancy[J].Nat Microbiol,2019,4(3):404-413.DOI:10.1038/s41564-018-0334-0.
[17] Kato A,Miyata I,Tanaka Y,et al.LAMP-based assay can rectify the diagnosis of Yersinia pseudotuberculosis infections otherwise missed by serology[J].J Med Microbiol,2019,68(2):143-147.DOI:10.1099/jmm.0.000868.
[18] Li Y,Zheng Q,Zou L,et al.Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition[J].Pediatr Rheumatol Online J,2019,17(1):1.DOI:10.1186/s12969-018-0303-4.
[19] Sugahara-Tobinai A,Inui M,Metoki T,et al.Augmented ILT3/LILRB4 expression of peripheral blood antibody secreting cells in the acute phase of kawasaki disease[J].Pediatr Infect Dis J,2019,38(4):431-438.DOI:10.1097/INF.0000000000002259.
[20] Li Z,Zhu WG.Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications[J].Int J Biol Sci,2014,10(7):757-770.DOI:10.7150/ijbs.9067.
[21] Zhang L,Liu N,Xie S,et al.HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process[J].Cancer Biol Ther,2014,15(11):1561-1570.DOI:10.4161/15384047.2014.956632.
[22] Morettin A,Baldwin RM,Côté J.Arginine methyltransferases as novel therapeutic targets for breast cancer[J].Mutagenesis,2015,30(2):177-189.DOI:10.1093/mutage/geu039.
|